SEC Form 3 · accession 0001209191-16-095643
Orexigen Therapeutics, Inc. · OREXQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather S Ace
Officer — EVP, Global Human Resources
Period of report
Jan 11, 2016
Accepted (ET)
Feb 4, 2016 · 11:58 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001382911
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No Securities are beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.